5th Circ. Upholds Abortion Pill's Approval, But Backs Limits

Summary

Law360 (August 16, 2023, 3:14 PM EDT) -- The Fifth Circuit on Wednesday rejected an extraordinary decision blocking the U.S. Food and Drug Administration's decades-old approval of the widely used abortion medication mifepristone, but also upheld the decision's reinstatement of restrictions on access to the medication.